MedPath

Effect of saqez cream on knee osteoarthritis

Not Applicable
Conditions
Osteoarthritis.
Primary arthrosis of other joints
Registration Number
IRCT201506073106N26
Lead Sponsor
Islamic Azad University, Pharmaceutical Sciences Branch
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
85
Inclusion Criteria

Patient's written consent; radiographic changes; primary knee osteoarthritis grade 2 and 3; age between 35 – 85; patients who did not receive topical treatment or received previous topical treatment for at least two weeks before they start on this trial. All patients must be stable on their current oral therapy.
Exclusion criteria:
Patients who needs more than 2 grams of acetaminophen in order to control pain; Those who need to use other oral or intravenous analgesics; Unwilling to continue or to participate in the study any further; Sensitivity to study drugs; Patients with other bone joint disorders: ( Rhumatoid Arthrities, Gout, Pseudo Gout, Infected Arthrities, Metabolic Arthrities, Traumatic Arthrities ) ; Infections and malignancy disease; Joint replacement; Fibro myalgia; Knee corticosteroid injection in the past 3 months, Pregnancy, oral and local use of corticosteroids; Pationts with active Renal, Liver and Peptic Ulcer Disease; Alcohol addicted; Drug Abuse

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Physical function. Timepoint: 2 Weeks,6 weeks and 12 weeks after baseline. Method of measurement: Womac questionaries.;Stiffness. Timepoint: 2 Weeks,6 weeks and 12 weeks after baseline. Method of measurement: Womac questionaries.;Pain. Timepoint: 2 Weeks,6 weeks and 12 weeks after baseline. Method of measurement: Womac questionaries.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath